Erin R Kulick1, Yeseon P Moon2, Ken Cheung3, Joshua Z Willey2, Ralph L Sacco4, Mitchell S V Elkind5. 1. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. Electronic address: erk2140@cumc.columbia.edu. 2. Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA. 3. Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA. 4. Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA; Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, FL, USA. 5. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Abstract
PURPOSE: To identify risk factors (RF) for diabetes within a multiethnic cohort and to examine whether race-ethnicity modified their effects. METHODS: Participants in the Northern Manhattan Study without diabetes at baseline were studied from 1993 to 2014 (n=2430). Weibull regression models with interval censoring data were fit to calculate hazard ratios and 95% confidence intervals for incident diabetes. We tested for interactions between RF and race-ethnicity. RESULTS: During a mean follow-up period of 11years, there were 449 diagnoses of diabetes. Being non-Hispanic black (HR 1.69 95% CI 1.11-2.59) or Hispanic (HR 2.25 95% CI 1.48-3.40) versus non-Hispanic white, and body mass index (BMI; HR 1.34 per SD 95% CI 1.21-1.49) were associated with greater risk of diabetes; high-density lipoprotein cholesterol (HR 0.75 95% CI 0.66-0.86) was protective. There were interactions by race-ethnicity. In stratified models, the effects of BMI, current smoking, and C-reactive protein (CRP) on risk of diabetes differed by race-ethnicity (p for interaction <0.05). The effects were greater among non-Hispanic whites than non-Hispanic blacks and Hispanics. CONCLUSIONS: Although Hispanics and non-Hispanic blacks had a greater risk of diabetes than whites, there were variations by race-ethnicity in the association of BMI, smoking, and CRP with risk of diabetes. Unique approaches should be considered to reduce diabetes as traditional RF may not be as influential in minority populations.
PURPOSE: To identify risk factors (RF) for diabetes within a multiethnic cohort and to examine whether race-ethnicity modified their effects. METHODS:Participants in the Northern Manhattan Study without diabetes at baseline were studied from 1993 to 2014 (n=2430). Weibull regression models with interval censoring data were fit to calculate hazard ratios and 95% confidence intervals for incident diabetes. We tested for interactions between RF and race-ethnicity. RESULTS: During a mean follow-up period of 11years, there were 449 diagnoses of diabetes. Being non-Hispanic black (HR 1.69 95% CI 1.11-2.59) or Hispanic (HR 2.25 95% CI 1.48-3.40) versus non-Hispanic white, and body mass index (BMI; HR 1.34 per SD 95% CI 1.21-1.49) were associated with greater risk of diabetes; high-density lipoprotein cholesterol (HR 0.75 95% CI 0.66-0.86) was protective. There were interactions by race-ethnicity. In stratified models, the effects of BMI, current smoking, and C-reactive protein (CRP) on risk of diabetes differed by race-ethnicity (p for interaction <0.05). The effects were greater among non-Hispanic whites than non-Hispanic blacks and Hispanics. CONCLUSIONS: Although Hispanics and non-Hispanic blacks had a greater risk of diabetes than whites, there were variations by race-ethnicity in the association of BMI, smoking, and CRP with risk of diabetes. Unique approaches should be considered to reduce diabetes as traditional RF may not be as influential in minority populations.
Authors: Paula A Braveman; Catherine Cubbin; Susan Egerter; Sekai Chideya; Kristen S Marchi; Marilyn Metzler; Samuel Posner Journal: JAMA Date: 2005-12-14 Impact factor: 56.272
Authors: Linda S Geiss; Liping Pan; Betsy Cadwell; Edward W Gregg; Stephanie M Benjamin; Michael M Engelgau Journal: Am J Prev Med Date: 2006-05 Impact factor: 5.043
Authors: Dilys J Freeman; John Norrie; Muriel J Caslake; Allan Gaw; Ian Ford; Gordon D O Lowe; Denis St J O'Reilly; Chris J Packard; Naveed Sattar Journal: Diabetes Date: 2002-05 Impact factor: 9.461
Authors: Joshua Z Willey; Yeseon P Moon; Mandip S Dhamoon; Erin R Kulick; Ahmet Bagci; Noam Alperin; Ying Kuen Cheung; Clinton B Wright; Ralph L Sacco; Mitchell S V Elkind Journal: Neuroepidemiology Date: 2018-06-28 Impact factor: 3.282
Authors: Martha Sajatovic; Douglas D Gunzler; Stephanie W Kanuch; Kristin A Cassidy; Curtis Tatsuoka; Richard McCormick; Carol E Blixen; Adam T Perzynski; Douglas Einstadter; Charles L Thomas; Mary E Lawless; Siobhan Martin; Corinna Falck-Ytter; Eileen L Seeholzer; Christine L McKibben; Mark S Bauer; Neal V Dawson Journal: Psychiatr Serv Date: 2017-05-15 Impact factor: 3.084
Authors: Michael P Bancks; Kiarri Kershaw; April P Carson; Penny Gordon-Larsen; Pamela J Schreiner; Mercedes R Carnethon Journal: JAMA Date: 2017-12-26 Impact factor: 56.272
Authors: April P Carson; D Leann Long; Andrea L Cherrington; Gareth R Dutton; Virginia J Howard; Todd M Brown; George Howard; Monika M Safford; Mary Cushman Journal: Am J Prev Med Date: 2020-12-02 Impact factor: 5.043
Authors: Jeannette M Beasley; Lindsey Kirshner; Judith Wylie-Rosett; Mary Ann Sevick; Laura DeLuca; Joshua Chodosh Journal: Pilot Feasibility Stud Date: 2019-11-11